Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intralesional Acyclovir Versus Intralesional Zinc Sulphate in the Treatment of Plantar Warts

NCT07848100 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT07848100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07848100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intralesional Acyclovir Versus Intralesional Zinc Sulphate in the Treatment of Plantar Warts
Lead sponsor
Assiut University
Phase
Phase 3
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
March 31, 2028
Enrollment
76 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

human papillomavirus infection, plantar warts, skin diseases, viral, warts